Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | DRD2 | P14416 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164538 | 0.81 | LMNA (0.67) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL576814 | 0.81 | LMNA (0.67) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL16924853 | 0.81 | LMNA (0.67) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL385012 | 0.81 | — | — | |
| SCHEMBL576454 | 0.81 | LMNA (0.67) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL2115191 | 0.78 | CHRNA7 (0.53) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL7258870 | 0.78 | LMNA (0.64) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL15361051 | 0.78 | CHRNA7 (0.58) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 | |
| SCHEMBL6153220 | 0.77 | ALDH1A1 (0.66) | ALDH1A1MAPTSIGMAR1DRD2MAPK1 | |
| Hydrochloric Acid SCHEMBL11552188 | 0.77 | CHRNA7 (0.52) | CHRNA7ALDH1A1MAPTSIGMAR1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3328958-B1 | USE OF A SINGLE OR MULTI COMPONENT SYSTEM FOR SECURING ANCHORING MEANS | FISCHERWERKE GMBH & CO KG (DE) | 2022-10-05 | — | — | EP | claimed |
| EP-3328959-B1 | USE OF A SINGLE-COMPONENT SYSTEM FOR SECURING ANCHORING MEANS | FISCHERWERKE GMBH & CO KG (DE) | 2020-06-03 | — | — | EP | claimed |
| EP-3328958-B1 | USE OF A SINGLE OR MULTI COMPONENT SYSTEM FOR SECURING ANCHORING MEANS | FISCHERWERKE GMBH & CO KG (DE) | 2022-10-05 | — | — | EP | disclosed |
| EP-3328959-A1 | USE OF A SINGLE-COMPONENT SYSTEM FOR SECURING ANCHORING MEANS | fischerwerke GmbH & Co. KG (DE) | 2018-06-06 | — | — | EP | disclosed |
| US-9024051-B2 | Organoxysilane compounds having silyl-protected secondary amino group and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-05-05 | — | — | US | disclosed |
| US-20130296593-A1 | ORGANOXYSILANE COMPOUNDS HAVING SILYL-PROTECTED SECONDARY AMINO GROUP AND MAKING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-11-07 | — | — | US | disclosed |
| EP-2660244-A1 | Organoxysilane compounds having silyl-protected secondary amino group and making method | Shin-Etsu Chemical Co., Ltd. (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20120165493-A1 | ISOCYANATE-FREE SILANE-CROSSLINKING COMPOUNDS | WACKER CHEMIE AG (DE) | 2012-06-28 | — | — | US | disclosed |
| US-8114233-B2 | Method for adhesive bonding with foamable mixtures containing alkoxysilane-terminated prepolymers | WACKER CHEMIE AG (DE) | 2012-02-14 | — | — | US | disclosed |
| US-7875658-B2 | Isocyanate-free prepolymer mixtures for producing noncracking spray foams and have improved fireproofing; a foamable polyetherurethane based on halogenated polyethers having alkoxysilane end groups and a blowing agent; shrinkage inhibition;nontoxic insulation; construction materials; seals | WACKER CHEMIE AG (DE) | 2011-01-25 | — | — | US | disclosed |
| US-20100324205-A1 | FLUID, FLUORINE-CONTAINING AND SINGLE-COMPONENT COMPOSITION | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2010-12-23 | — | — | US | disclosed |
| US-20090198000-A1 | Liquid fluorine-containing and two-component compositions for the surface treatment of mineral and non-mineral substrates | EVONIK DEGUSSA GMBH (DE) | 2009-08-06 | — | — | US | disclosed |
| US-7550517-B2 | Expandable mixtures that are devoid of isocyanates | WACKER CHEMIE AG (DE) | 2009-06-23 | — | — | US | disclosed |
| EP-1348747-B1 | Gas barrier coating composition and method for manufacturing same | JSR CORP (JP) | 2007-02-14 | — | — | EP | disclosed |
| US-20060189705-A1 | Expandable mixtures that are devoid of isocyanates | WACKER CHEMIE AG (DE) | 2006-08-24 | — | — | US | disclosed |
| US-20060148921-A1 | Expansible mixtures devoid of isocyanates exhibiting improved fire behaviour | WACKER CHEMIE AG (DE) | 2006-07-06 | — | — | US | disclosed |
| US-20060084711-A1 | Foaming mixtures | WACKER CHEMIE AG (DE) | 2006-04-20 | — | — | US | disclosed |
| US-20040072921-A1 | Polyurethane modified with organosilicon compound | WACKER CHEMIE AG (DE) | 2004-04-15 | — | — | US | disclosed |
| US-20030187113-A1 | Gas barrier coating composition and method for manufacturing same | JSR CORPORATION (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1348747-A1 | Gas barrier coating composition and method for manufacturing same | JSR Corporation (JP) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296593-A1 | ORGANOXYSILANE COMPOUNDS HAVING SILYL-PROTECTED SECONDARY AMINO GROUP AND MAKING METHOD | AS3MT, SUGT1, PNMT | CHRNA7 4589/4885ALDH1A1 2214/4885MAPT 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.